Okayama prospective oBservational study of the Effect by Sitagliptin on obesE type2 diabetes

Trial Profile

Okayama prospective oBservational study of the Effect by Sitagliptin on obesE type2 diabetes

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Aug 2015

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Biomarker; Therapeutic Use
  • Acronyms OBESE
  • Most Recent Events

    • 04 Aug 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 05 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 20 Mar 2012 Planned End Date changed from 1 Sep 2013 to 1 Mar 2014 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top